Atrial natriuretic peptide in chronic renal failure on maintenance hemodialysis : effect of heart failure
Author
Source
Annals of the College of Medicine Mosul
Issue
Vol. 31, Issue 1 (30 Jun. 2005), pp.32-36, 5 p.
Publisher
University of Mosul College of Medicine-Mosul
Publication Date
2005-06-30
Country of Publication
Iraq
No. of Pages
5
Main Subjects
Abstract EN
objective: To examine the plasma level of atrial natriuretic peptide(ANP) in patients withchronic renal failure (CRF) undergoing maintenance hemodialysis ( HD) and to evaluate theeffect of superimposed cardiac functional impairment on the plasma level of this hormone.Design: A case- series studySetting: Artificial Kidney and Dialysis Unit of lbn-Sena Teaching Hospital, Mosul; during theperiod from June 2003 to August 2004.Participants: Forty patients with CRF undergoing maintenance HD, were divided into 2 groups depending on presence or absence of heart 6itu[.
Group l, includes 20 patients with CRF who did not have heart failure and group Il, includes 20 patients with CRF who had heart failure, The study also includes 20 healthy volunteers as a control group.Methods: Plasma ANP, serum creatinine, urea and body weights were measured in CRFpatients before and after HD.
The same parameters were also measured in the control group.The paired-t-test was used to examine the difference in the mean of the studied parameters in patients with CRF before and after HD.
The unpaired -t- test was used to assess the difference in the mean of the above-mentioned parameters between patients and control group.
Pearson correlation coefficient was used to study the relation of the means of differences between pre and post dialysis values of the studied parameters within each patient group.Results: The mean of plasma ANP level was significantly higher in group I (p<0.0001) andgroup ll (p<0.0001) than that in the control group before and after HD.
Furthermore, the plasma ANP in group ll was significantly higher (p<0.0001) than that in group I.
There was a significant decrease in the plasma ANP in group I (pconclusion: Periodic measurement of plasma ANP level in patients with CRF may be of greatvalue in evaluating the actual fluid status in patients having CRI and in determination offrequency and duration of dialysis sessions.
lt also may be of value in predicting cardiacdysfunction in patients with CRF.Key words: Atrial natriuetic peptide, chronic renal failure, haemodialysis.
American Psychological Association (APA)
Aziz, Abd al-Aziz Ahmad. 2005. Atrial natriuretic peptide in chronic renal failure on maintenance hemodialysis : effect of heart failure. Annals of the College of Medicine Mosul،Vol. 31, no. 1, pp.32-36.
https://search.emarefa.net/detail/BIM-361782
Modern Language Association (MLA)
Aziz, Abd al-Aziz Ahmad. Atrial natriuretic peptide in chronic renal failure on maintenance hemodialysis : effect of heart failure. Annals of the College of Medicine Mosul Vol. 31, no. 1 (2005), pp.32-36.
https://search.emarefa.net/detail/BIM-361782
American Medical Association (AMA)
Aziz, Abd al-Aziz Ahmad. Atrial natriuretic peptide in chronic renal failure on maintenance hemodialysis : effect of heart failure. Annals of the College of Medicine Mosul. 2005. Vol. 31, no. 1, pp.32-36.
https://search.emarefa.net/detail/BIM-361782
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references : p. 35-36
Record ID
BIM-361782